Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Neutron Therapeutics and Cosylab Announce Strategic Collaboration to Bring Boron Neutron Capture Therapy to Patients
Wednesday, January 12, 2022Neutron Therapeutics a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy BNCT and Cosylab the worlds leading provider of control systems for the planets most complex machines today announced the...
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies
Tuesday, January 11, 2022Century Therapeutics and Bristol Myers Squibb announced a research collaboration and license agreement the agreement to develop and commercialize up to four induced pluripotent stem cell iPSC derived engineered natural killer cell iNK and or T cell...
Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
Tuesday, January 11, 2022Pfizer Inc and Acuitas Therapeutics a company focused on developing lipid nanoparticle LNP delivery systems to enable messenger RNA mRNAbased therapeutics today announced they have entered into a Development and Option agreement under which Pfizer wi...
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
Monday, January 10, 2022Bayer AG and Mammoth Biosciences Inc which is harnessing the diversity of nature to power the nextgeneration CRISPR products today announced a strategic collaboration and option agreement for the use of Mammoths CRISPR systems to develop in vivo gene...
Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
Monday, January 10, 2022Novartis and Molecular Partners today announced that Part A of the EMPATHY clinical trial that compared single intravenous doses of ensovibep a DARPin antiviral therapeutic candidate vs placebo to treat COVID met the primary endpoint of viral load re...
TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation
Friday, January 07, 2022TRexBio Inc a discovery stage company decoding tissue immune biology to create revolutionary therapeutics today announced that it has entered into a multiyear research collaboration and licensing agreement with Janssen Pharmaceutica NV one of the Jan...
Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement
Friday, January 07, 2022Amgen and Generate Biomedicines today announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across several therapeutic areas and multiple modalities As part of the research collaboration Am...
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Thursday, January 06, 2022Pfizer Inc and BioNTech SE announced a new research development and commercialization collaboration to develop a potential first mRNAbased vaccine for the prevention of shingles herpes zoster virus or HZV a debilitating disfiguring and painful diseas...
SRI International Announces Collaboration Agreement with Janssen
Thursday, January 06, 2022SRI International SRI announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV Janssen one of the Janssen Pharmaceutical Companies of Johnson Johnson Under the terms of the agreement the organizations and their...
Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer
Wednesday, January 05, 2022Genprex Inc a clinicalstage gene therapy company focused on developing lifechanging therapies for patients with cancer and diabetes today announced that it has expanded its oncology research and development pipeline to include small cell lung cancer...